Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04416984 |
|---|---|
| Brief Title: | Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma (ALPHA-2) (ALPHA-2) |
| First Submitted : | May 29, 2020 |
| First Submitted that Met QC Criteria : | June 2, 2020 |
| First Posted : | June 4, 2020 |
| Last Update Submitted that Met QC Criteria : | October 13, 2021 |
| Last Update Posted : | October 14, 2021 |